These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17536510)

  • 1. [Molecular methods for diagnostics and assessment of treatment effectiveness in modern pediatric hematooncology].
    Dawidowska M; Wachowiak J; Witt M
    Postepy Biochem; 2006; 52(4):408-16. PubMed ID: 17536510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for minimal residual disease levels in the treatment of ALL patients who receive allogeneic stem cells?
    Schilham MW; Balduzzi A; Bader P;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S49-52. PubMed ID: 15812531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction.
    Masmas TN; Madsen HO; Petersen SL; Ryder LP; Svejgaard A; Alizadeh M; Vindeløv LL
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):558-66. PubMed ID: 15983556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
    Pulsipher MA; Bader P; Klingebiel T; Cooper LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Minimal residual disease in childhood acute leukemias].
    Pawińska K; Balwierz W; Baran J
    Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimerism versus minimal residual disease monitoring after allogeneic transplantation--when do we act and will intervention improve outcomes?
    Pulsipher MA
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1461-2. PubMed ID: 25079876
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
    Willasch A; Schneider G; Reincke BS; Shayegi N; Kreyenberg H; Kuci S; Weber G; Van Der Reijden B; Niethammer D; Klingebiel T; Bader P
    Lab Hematol; 2007; 13(3):73-84. PubMed ID: 17984038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.
    Bacher U; Badbaran A; Fehse B; Zabelina T; Zander AR; Kröger N
    Exp Hematol; 2009 Jan; 37(1):135-42. PubMed ID: 19100523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
    Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
    Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of simplified strategies to evaluate early treatment response in childhood acute lymphoblastic leukemia.
    Scrideli CA; de Paula Queiróz R; Bernardes JE; Defavery R; Valera ET; Tone LG
    Leuk Res; 2006 Aug; 30(8):1049-52. PubMed ID: 16406015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-transplant minimal residual disease in children with acute lymphoblastic leukemia.
    Mehta PA; Davies SM
    Pediatr Blood Cancer; 2007 Jan; 48(1):1-2. PubMed ID: 16642487
    [No Abstract]   [Full Text] [Related]  

  • 12. [Roles of molecular analysis in hematopoietic stem cell transplantation].
    Hino M; Yamamura R; Fujino K
    Rinsho Byori; 2002 Nov; Suppl 123():201-6. PubMed ID: 12652810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring minimal residual disease in pediatric hematologic malignancies.
    Campana D
    Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme.
    Khan F; Agarwal A; Agrawal S
    Bone Marrow Transplant; 2004 Jul; 34(1):1-12. PubMed ID: 15156163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
    Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
    Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of four MRD markers in MRD-based treatment strategy for childhood acute lymphoblastic leukemia.
    Sawada A; Sakata N; Kishimoto T; Higuchi B; Koyama M; Kondo O; Sato E; Okamura T; Yasui M; Inoue M; Yoshioka A; Kawa K
    Leuk Res; 2009 Dec; 33(12):1710-3. PubMed ID: 19596431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of minimal residual disease in adult Ph1 positive acute lymphoblastic leukemia by a combination of cell sorting and fluorescence in situ hybridization: a preliminary study on 6 cases.
    Cambier N; Soenen-Cornu V; Laï JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 2000 Jun; 85(6):664-5. PubMed ID: 10870127
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers.
    Thiede C
    Am J Pharmacogenomics; 2004; 4(3):177-87. PubMed ID: 15174899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.